Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 160

1.

[Factors limiting outpatient management in breast surgery].

Rauch P, Salleron J, Buhler J, Leufflen L, Marchal F.

Bull Cancer. 2019 Oct 15. pii: S0007-4551(19)30334-0. doi: 10.1016/j.bulcan.2019.08.018. [Epub ahead of print] French.

PMID:
31627904
2.

Somatic substitution signature as an innovative tool in lung cancer diagnosis.

Busca S, Salleron J, Boidot R, Merlin JL, Harlé A.

Sci Rep. 2019 Oct 10;9(1):14561. doi: 10.1038/s41598-019-51155-3.

3.

Predictive factors of axillary positive sentinel lymph node biopsy in extended ductal carcinoma in situ treated by simple mastectomy at once.

Hotton J, Salleron J, Rauch P, Buhler J, Pierret M, Baumard F, Leufflen L, Marchal F.

J Gynecol Obstet Hum Reprod. 2019 Sep 25:101641. doi: 10.1016/j.jogoh.2019.101641. [Epub ahead of print]

PMID:
31562936
4.

[Evaluation of the management and conformity to clinical practice guidelines of soft tissues lesions. Study performed at the competence center of Lorraine area].

Genet J, Salleron J, Leroux A, Verhaeghe JL, Simon E.

Ann Chir Plast Esthet. 2019 Aug;64(4):326-333. doi: 10.1016/j.anplas.2018.10.001. Epub 2018 Oct 26. French.

PMID:
31387726
5.

Surgery or Radiotherapy of the Primary Tumor in T1-2 Head and Neck Squamous Cell Carcinoma with Resectable N3 Nodes: A Multicenter GETTEC Study.

Carsuzaa F, Thariat J, Gorphe P, Righini C, Cosmidis A, Thureau S, Roge M, De Mones E, Servagi-Vernat S, Tonnerre D, Morinière S, Dugas A, Malard O, Pasquier F, Vergez S, Salleron J, Dufour X.

Ann Surg Oncol. 2019 Oct;26(11):3673-3680. doi: 10.1245/s10434-019-07589-0. Epub 2019 Jul 1.

PMID:
31264120
6.

10-Year Locoregional Control with Postoperative External Beam Radiotherapy in Patients with Locally Advanced High-Risk Non-Anaplastic Thyroid Carcinoma De Novo or at Relapse, a Propensity Score Analysis.

Servagi Vernat S, Khalifa J, Sun XS, Kammerer E, Blais E, Faivre JC, Sio TT, Pan J, Qiu H, Bar-Sela G, Simon JM, Salleron J, Thariat J.

Cancers (Basel). 2019 Jun 19;11(6). pii: E849. doi: 10.3390/cancers11060849.

7.

[Systematic second opinion review of outside imaging in breast cancer diagnosis: An added value].

Boudier J, Oldrini G, Henrot P, Salleron J, Lesur A.

Bull Cancer. 2019 Apr;106(4):316-327. doi: 10.1016/j.bulcan.2019.01.019. Epub 2019 Mar 15. French.

PMID:
30885367
8.

Ifosfamide-induced encephalopathy: Brand-name (HOLOXAN®) vs generic formulation (IFOSFAMIDE EG®).

Chambord J, Henny F, Salleron J, Hombourger B, Lider P, Vigneron J, Demore B, Vallance C, Rios M.

J Clin Pharm Ther. 2019 Jun;44(3):372-380. doi: 10.1111/jcpt.12823. Epub 2019 Mar 4.

PMID:
30830971
9.

Unilateral or bilateral irradiation in cervical lymph node metastases of unknown primary? A retrospective cohort study.

Pflumio C, Troussier I, Sun XS, Salleron J, Petit C, Caubet M, Beddok A, Calugaru V, Servagi-Vernat S, Castelli J, Miroir J, Krengli M, Giraud P, Romano E, Khalifa J, Doré M, Blanchard N, Coutte A, Dupin C, Sumodhee S, Pointreau Y, Patel S, Rehailia-Blanchard A, Catteau L, Bensadoun RJ, Tao Y, Roth V, Geoffrois L, Faivre JC, Thariat J.

Eur J Cancer. 2019 Apr;111:69-81. doi: 10.1016/j.ejca.2019.01.004. Epub 2019 Feb 28.

PMID:
30826659
10.

Intensity-modulated radiation therapy of anal squamous cell carcinoma: Relationship between delineation quality and regional recurrence.

Rouard N, Peiffert D, Rio E, Mahé MA, Delpon G, Marchesi V, Falk AT, Salleron J, Serre AA.

Radiother Oncol. 2019 Feb;131:93-100. doi: 10.1016/j.radonc.2018.10.021. Epub 2018 Dec 31.

PMID:
30773194
11.

The Lens Opacities Classification System III Grading in Irradiated Uveal Melanomas to Characterize Proton Therapy-Induced Cataracts.

Mathis T, Rosier L, Meniai F, Baillif S, Maschi C, Herault J, Caujolle JP, Kodjikian L, Salleron J, Thariat J.

Am J Ophthalmol. 2019 May;201:63-71. doi: 10.1016/j.ajo.2019.01.025. Epub 2019 Feb 2.

PMID:
30721686
12.

Self-compression Technique vs Standard Compression in Mammography: A Randomized Clinical Trial.

Henrot P, Boisserie-Lacroix M, Boute V, Troufléau P, Boyer B, Lesanne G, Gillon V, Desandes E, Netter E, Saadate M, Tardivon A, Grentzinger C, Salleron J, Oldrini G.

JAMA Intern Med. 2019 Mar 1;179(3):407-414. doi: 10.1001/jamainternmed.2018.7169.

PMID:
30715083
13.

Management of Invasive Squamous Cell Carcinomas of the Conjunctiva.

Santoni A, Thariat J, Maschi C, Herault J, Baillif S, Lassalle S, Peyrichon ML, Salleron J, Caujolle JP.

Am J Ophthalmol. 2019 Apr;200:1-9. doi: 10.1016/j.ajo.2018.11.024. Epub 2018 Dec 12.

PMID:
30552889
14.

Comparison of Three Real-Time PCR Assays for the Detection of PIK3CA Somatic Mutations in Formalin-Fixed Paraffin Embedded Tissues of Patients with Breast Carcinomas.

Lambert A, Salleron J, Lion M, Rouyer M, Lozano N, Leroux A, Merlin JL, Harlé A.

Pathol Oncol Res. 2019 Jul;25(3):1117-1123. doi: 10.1007/s12253-018-0538-x. Epub 2018 Nov 13.

PMID:
30426328
15.

Low risk of invasive lobular carcinoma of the breast in carriers of BRCA1 (hereditary breast and ovarian cancer) and TP53 (Li-Fraumeni syndrome) germline mutations.

Ditchi Y, Broudin C, El Dakdouki Y, Muller M, Lavaud P, Caron O, Lejri D, Baynes C, Mathieu MC, Salleron J, Benusiglio PR.

Breast J. 2019 Jan;25(1):16-19. doi: 10.1111/tbj.13154. Epub 2018 Nov 9.

PMID:
30414230
16.

Cyberknife® stereotactic radiation therapy for stage I lung cancer and pulmonary metastases: evaluation of local control at 24 months.

Khadige M, Salleron J, Marchesi V, Oldrini G, Peiffert D, Beckendorf V.

J Thorac Dis. 2018 Aug;10(8):4976-4984. doi: 10.21037/jtd.2018.07.26.

17.

Accelerated BRAF mutation analysis using a fully automated PCR platform improves the management of patients with metastatic melanoma.

Serre D, Salleron J, Husson M, Leroux A, Gilson P, Merlin JL, Geoffrois L, Harlé A.

Oncotarget. 2018 Aug 14;9(63):32232-32237. doi: 10.18632/oncotarget.25957. eCollection 2018 Aug 14.

18.

Prostate-specific antigen bounce in patients treated before 60 years old by iodine 125 brachytherapy for prostate cancer is frequent and not a prognostic factor.

Charret J, Baumann AS, Eschwege P, Moreau JL, Bernier V, Falk AT, Salleron J, Peiffert D.

Brachytherapy. 2018 Nov - Dec;17(6):888-894. doi: 10.1016/j.brachy.2018.07.011. Epub 2018 Aug 29.

PMID:
30172752
19.

Practical contouring guidelines with an MR-based atlas of brainstem structures involved in radiation-induced nausea and vomiting.

Beddok A, Faivre JC, Coutte A, Guévelou JL, Welmant J, Clavier JB, Guihard S, Janoray G, Calugaru V, Pointreau Y, Lacout A, Salleron J, Lefranc M, Hasboun D, Duvernoy HM, Thariat J.

Radiother Oncol. 2019 Jan;130:113-120. doi: 10.1016/j.radonc.2018.08.003. Epub 2018 Aug 29.

PMID:
30172454
20.

Prognostic factors of colostomy free survival in patients presenting with locally advanced anal canal carcinoma: A pooled analysis of two prospective trials (KANAL 2 and ACCORD 03).

Faivre JC, Peiffert D, Vendrely V, Lemanski C, Hannoun-Levi JM, Mirabel X, Stanbury T, Salleron J, Guillemin F.

Radiother Oncol. 2018 Dec;129(3):463-470. doi: 10.1016/j.radonc.2018.08.008. Epub 2018 Aug 29.

PMID:
30172453
21.

Evaluation and validation of HPV real-time PCR assay for the detection of HPV DNA in oral cytobrush and FFPE samples.

Harlé A, Guillet J, Thomas J, Sastre-Garau X, Rouyer M, Ramacci C, Gilson P, Dubois C, Dolivet G, Leroux A, Salleron J, Merlin JL.

Sci Rep. 2018 Jul 27;8(1):11313. doi: 10.1038/s41598-018-29790-z.

22.

Oral surgery: Perio disease and flap reconstruction failure.

Egloff-Juras C, Salleron J, Phulpin B, Dolivet G.

Br Dent J. 2018 Jul 13;225(1):4. doi: 10.1038/sj.bdj.2018.556. No abstract available.

PMID:
30002552
23.

Validation of a high performance functional assay for individual radiosensitivity in pediatric oncology: a prospective cohort study (ARPEGE).

Bernier-Chastagner V, Hettal L, Gillon V, Fernandes L, Huin-Schohn C, Vazel M, Tosti P, Salleron J, François A, Cérimèle E, Perreira S, Peiffert D, Chastagner P, Vogin G.

BMC Cancer. 2018 Jul 6;18(1):719. doi: 10.1186/s12885-018-4652-7.

24.

Photodynamic diagnosis with methyl-5-aminolevulinate in squamous intraepithelial lesions of the vulva: Experimental research.

Leufflen L, Francois A, Salleron J, Barlier C, Dolivet G, Marchal F, Bezdetnaya L.

PLoS One. 2018 May 9;13(5):e0196753. doi: 10.1371/journal.pone.0196753. eCollection 2018.

25.

Impact of rectal distension on prostate CBCT-based positioning assessed with 6 degrees-of-freedom couch.

Charret J, Salleron J, Quivrin M, Mazoyer F, Lesueur P, Martin E, Peiffert D, Créhange G.

Pract Radiat Oncol. 2018 Sep - Oct;8(5):e322-e328. doi: 10.1016/j.prro.2018.03.001. Epub 2018 Mar 9.

PMID:
29706305
26.

[Refusal of treatments by an adult cancer patient].

Dauchy S, Faivre JC, Block V, Metzger M, Salleron J, Charles C, Adam V.

Bull Cancer. 2018 Mar;105(3):234-244. doi: 10.1016/j.bulcan.2017.11.016. Epub 2018 Feb 23. French.

PMID:
29478572
27.

Pattern multiplicity and fumarate hydratase (FH)/S-(2-succino)-cysteine (2SC) staining but not eosinophilic nucleoli with perinucleolar halos differentiate hereditary leiomyomatosis and renal cell carcinoma-associated renal cell carcinomas from kidney tumors without FH gene alteration.

Muller M, Guillaud-Bataille M, Salleron J, Genestie C, Deveaux S, Slama A, de Paillerets BB, Richard S, Benusiglio PR, Ferlicot S.

Mod Pathol. 2018 Jun;31(6):974-983. doi: 10.1038/s41379-018-0017-7. Epub 2018 Feb 6.

28.

Choosing a career in oncology: results of a nationwide cross-sectional study.

Faivre JC, Bibault JE, Bellesoeur A, Salleron J, Wack M, Biau J, Cervellera M, Janoray G, Leroy T, Lescut N, Martin V, Molina S, Pichon B, Teyssier C, Thureau S, Mazeron JJ, Roché H, Culine S.

BMC Med Educ. 2018 Jan 15;18(1):15. doi: 10.1186/s12909-018-1117-2.

29.

Impact of an abbreviated protocol for breast MRI in diagnostic accuracy.

Oldrini G, Derraz I, Salleron J, Marchal F, Henrot P.

Diagn Interv Radiol. 2018 Jan-Feb;24(1):12-16. doi: 10.5152/dir.2018.16609.

30.

The prognostic value of inflammation-based scores in advanced hepatocellular carcinoma patients prior to treatment with sorafenib.

Conroy G, Salleron J, Belle A, Bensenane M, Nani A, Ayav A, Peiffert D, Lopez A, Baumann C, Barraud H, Bronowicki JP.

Oncotarget. 2017 Sep 30;8(56):95853-95864. doi: 10.18632/oncotarget.21401. eCollection 2017 Nov 10.

31.

[Prophylactic radiotherapy in a single fraction of 10Gy at intervention pleural site in patient with malignant pleural mesothelioma: A retrospective monocentric cohort study].

Carette H, Faivre JC, Salleron J, Baumann AS, Uwer L, Clément-Duchêne C, Vignaud JM, Petit I, Siat J, Tiotiu A, Beckendorf V.

Cancer Radiother. 2017 Dec;21(8):774-783. doi: 10.1016/j.canrad.2017.06.011. Epub 2017 Nov 11. French.

PMID:
29132802
32.

Proton Beam Therapy for Iris Melanomas in 107 Patients.

Thariat J, Rahmi A, Salleron J, Mosci C, Butet B, Maschi C, Lanza F, Lanteri S, Baillif S, Herault J, Mathis T, Caujolle JP.

Ophthalmology. 2018 Apr;125(4):606-614. doi: 10.1016/j.ophtha.2017.10.009. Epub 2017 Nov 8.

PMID:
29128229
33.

Modern robot-assisted radiosurgery of cerebral angiomas-own experiences, system comparisons, and comprehensive literature overview.

Feutren T, Huertas A, Salleron J, Anxionnat R, Bracard S, Klein O, Peiffert D, Bernier-Chastagner V.

Neurosurg Rev. 2018 Jul;41(3):787-797. doi: 10.1007/s10143-017-0926-9. Epub 2017 Nov 5. Review.

PMID:
29105011
34.

Cataract Avoidance With Proton Therapy in Ocular Melanomas.

Thariat J, Jacob S, Caujolle JP, Maschi C, Baillif S, Angellier G, Mathis T, Rosier L, Carnicer A, Hérault J, Salleron J.

Invest Ophthalmol Vis Sci. 2017 Oct 1;58(12):5378-5386. doi: 10.1167/iovs.17-22557.

PMID:
29049739
35.

Denosumab-related osteonecrosis of the jaw: A retrospective study.

Egloff-Juras C, Gallois A, Salleron J, Massard V, Dolivet G, Guillet J, Phulpin B.

J Oral Pathol Med. 2018 Jan;47(1):66-70. doi: 10.1111/jop.12646. Epub 2017 Oct 28.

PMID:
28977694
36.

A retrospective cohort study to assess adjuvant concurrent chemoradiation (CCRT) compared to adjuvant radiation therapy (RT) in the treatment of grade 2 and 3 extremity soft tissue sarcomas.

Nesseler JP, Salleron J, Rios M, Nickers P, Marchal F, Brocard F, Peiffert D, Vogin G.

Radiother Oncol. 2017 Oct;125(1):160-167. doi: 10.1016/j.radonc.2017.08.037. Epub 2017 Sep 23.

PMID:
28951009
37.

[Impact of the preservation of the branches of intercostobrachial nerve on the quality of life of patients operated for a breast cancer].

Saleh Z, Salleron J, Baffert S, Paveau A, Classe JM, Marchal F.

Bull Cancer. 2017 Oct;104(10):858-868. doi: 10.1016/j.bulcan.2017.08.002. Epub 2017 Sep 14. French.

PMID:
28917551
38.

[Hypofractionated stereotactic radiotherapy for brain metastasis: Benefit of additional whole brain radiotherapy?]

Royer P, Salleron J, Vogin G, Taillandier L, Clément-Duchêne C, Klein O, Faivre JC, Peiffert D, Bernier V.

Cancer Radiother. 2017 Dec;21(8):731-740. doi: 10.1016/j.canrad.2017.02.005. Epub 2017 Jul 12. French.

PMID:
28711413
39.

Effect of bladder distension on doses to organs at risk in Pulsed-Dose-Rate 3D image-guided adaptive brachytherapy for locally advanced cervical cancer.

Nesseler JP, Charra-Brunaud C, Salleron J, Py JF, Huertas A, Meknaci E, Courrech F, Peiffert D, Renard-Oldrini S.

Brachytherapy. 2017 Sep - Oct;16(5):976-980. doi: 10.1016/j.brachy.2017.06.003. Epub 2017 Jul 8.

PMID:
28694116
40.

[Teaching pediatrics to residents via conventional lectures in France: A national survey from students].

Girard B, Bendavid M, Faivre JC, Salleron J, Debillon T, Claris O, Chabrol B, Schweitzer C, Gajdos V.

Arch Pediatr. 2017 Aug;24(8):728-736. doi: 10.1016/j.arcped.2017.05.009. Epub 2017 Jun 29. French.

PMID:
28669648
41.

Intensity-modulated radiation therapy from 70Gy to 80Gy in prostate cancer: six- year outcomes and predictors of late toxicity.

Jolnerovski M, Salleron J, Beckendorf V, Peiffert D, Baumann AS, Bernier V, Huger S, Marchesi V, Chira C.

Radiat Oncol. 2017 Jun 16;12(1):99. doi: 10.1186/s13014-017-0839-3.

42.

Clinical practice guidelines of the French Association for Supportive Care in Cancer and the French Society for Psycho-oncology: refusal of treatment by adults afflicted with cancer.

Faivre JC, Adam V, Block V, Metzger M, Salleron J, Dauchy S.

Support Care Cancer. 2017 Nov;25(11):3425-3435. doi: 10.1007/s00520-017-3762-0. Epub 2017 Jun 8.

PMID:
28597252
43.

Dry Eye Syndrome After Proton Therapy of Ocular Melanomas.

Thariat J, Maschi C, Lanteri S, Peyrichon ML, Baillif S, Herault J, Salleron J, Caujolle JP.

Int J Radiat Oncol Biol Phys. 2017 May 1;98(1):142-151. doi: 10.1016/j.ijrobp.2017.01.199. Epub 2017 Jan 29.

PMID:
28586953
44.

[Comparison of survival and chronic gastrointestinal toxicities in patients with locally advanced cervical cancer, treated by conventional or intensity-modulated radiation technique].

Gamelon-Bénichou C, Oldrini S, Charra-Brunaud C, Vogin G, Salleron J, Peiffert D.

Cancer Radiother. 2017 May;21(3):171-179. doi: 10.1016/j.canrad.2016.11.007. Epub 2017 Apr 28. French.

PMID:
28457817
45.

Tumor response assessment by MRI following stereotactic body radiation therapy for hepatocellular carcinoma.

Oldrini G, Huertas A, Renard-Oldrini S, Taste-George H, Vogin G, Laurent V, Salleron J, Henrot P.

PLoS One. 2017 Apr 25;12(4):e0176118. doi: 10.1371/journal.pone.0176118. eCollection 2017.

46.

Evaluation of the Theoretical Teaching of Postgraduate Radiation Oncology Medical Residents in France: a Cross-Sectional Study.

Faivre JC, Bibault JE, Leroy T, Agopiantz M, Salleron J, Wack M, Janoray G, Roché H, Culine S, Rivera S.

J Cancer Educ. 2018 Apr;33(2):383-390. doi: 10.1007/s13187-017-1170-2.

PMID:
28138918
47.

Comparison of Five Different Assays for the Detection of BRAF Mutations in Formalin-Fixed Paraffin Embedded Tissues of Patients with Metastatic Melanoma.

Franczak C, Salleron J, Dubois C, Filhine-Trésarrieu P, Leroux A, Merlin JL, Harlé A.

Mol Diagn Ther. 2017 Apr;21(2):209-216. doi: 10.1007/s40291-017-0258-z.

PMID:
28130756
48.

Dynamic MR defecography of the posterior compartment: Comparison with conventional X-ray defecography.

Poncelet E, Rock A, Quinton JF, Cosson M, Ramdane N, Nicolas L, Feldmann A, Salleron J.

Diagn Interv Imaging. 2017 Apr;98(4):327-332. doi: 10.1016/j.diii.2016.03.018. Epub 2017 Jan 11.

49.

Beside P53 and PTEN: Identification of molecular alterations of the RAS/MAPK and PI3K/AKT signaling pathways in high-grade serous ovarian carcinomas to determine potential novel therapeutic targets.

Chen S, Cavazza E, Barlier C, Salleron J, Filhine-Tresarrieu P, Gavoilles C, Merlin JL, Harlé A.

Oncol Lett. 2016 Nov;12(5):3264-3272. Epub 2016 Sep 2.

50.

Post-operative recurrence of Crohn's disease after definitive stoma: an underestimated risk.

Koriche D, Gower-Rousseau C, Chater C, Duhamel A, Salleron J, Tavernier N, Colombel JF, Pariente B, Cortot A, Zerbib P.

Int J Colorectal Dis. 2017 Apr;32(4):453-458. doi: 10.1007/s00384-016-2707-2. Epub 2016 Nov 24.

PMID:
27885481

Supplemental Content

Loading ...
Support Center